論文

国際誌
2020年10月3日

A multi-center, prospective study on the progression rate of asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on magnetic resonance imaging to idiopathic normal pressure hydrocephalus.

Journal of the neurological sciences
  • Luna Kimihira
  • Chifumi Iseki
  • Yoshimi Takahashi
  • Hidenori Sato
  • Hajime Kato
  • Hiroaki Kazui
  • Nagato Kuriyama
  • Madoka Nakajima
  • Masakazu Miyajima
  • Katsuhiro Endo
  • Yoshio Kobayashi
  • Takashi Saegusa
  • Yasuaki Takeda
  • Shunsuke Sato
  • Yusuke Tomogane
  • Toru Baba
  • Hiroji Miyake
  • Mitsunori Matsumae
  • Satoshi Onozuka
  • Hisayuki Murai
  • Yoshinaga Kajimoto
  • Teruo Kimura
  • Masahito Kobayashi
  • Masashi Yamazaki
  • Hajime Arai
  • Takeo Kato
  • 全て表示

419
開始ページ
117166
終了ページ
117166
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.jns.2020.117166

INTRODUCTION: Our previous community-based study demonstrated that some individuals with AVIM [asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus (iNPH) on magnetic resonance imaging (MRI)] progressed to iNPH in several years. In this hospital-based study, we investigated the progression rate from AVIM to iNPH and its possible predictors. METHODS: We conducted a prospective study of participants with AVIM from several medical institutions/hospitals in Japan. AVIM is defined as "asymptomatic ventriculomegaly with features of iNPH on MRI"; in the present study, asymptomatic was defined as "0 (no symptoms) or 1 (presence of only subjective, but not objective, symptoms) on the iNPH Grading Scale (iNPH-GS)." We also measured possible predicting factors for AVIM-to-iNPH progression, including age, sex, body weight, blood pressure, diabetes mellitus, dyslipidemia, history of mental disease/head injury/sinusitis/smoking/alcohol-intake, Evans index, and the presence of DESH (disproportionately enlarged subarachnoid-space hydrocephalus) findings on brain MRI, and analyzed these potential predictive values. RESULTS: In 2012, 93 participants with AVIM were registered and enrolled in the study. Of these, 52 participants were able to be tracked for three years (until 2015). Of the 52 participants, 27 (52%) developed iNPH during the follow-up period (11 definite, 6 probable, and 10 possible iNPH), whereas 25 participants remained asymptomatic in 2015. Among the possible predictive factors examined, the baseline scores of iNPH-GS predicted the AVIM-to-iNPH progression. CONCLUSIONS: The multicenter prospective study demonstrated that the progression rate from AVIM to iNPH was ~17% per year, and the baseline scores of iNPH-GS predicted the AVIM-to-iNPH progression.

リンク情報
DOI
https://doi.org/10.1016/j.jns.2020.117166
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33065495
ID情報
  • DOI : 10.1016/j.jns.2020.117166
  • PubMed ID : 33065495

エクスポート
BibTeX RIS